CNTX Context Therapeutics Inc
Company Analysis
Latest News
🔴 Context Therapeutics is trading 5.3% down today on follow-through selling after recent volatility
Context Therapeutics is trading at $0.56 (5.3% down), extending its downward trend after a 14.9% drop on July 8 and a week marked by significant double-digit...
🟢 Context Therapeutics is trading 5.8% up today in a technical bounce after recent losses
Context Therapeutics is trading at $0.63 (5.8% up) in pre-market, staging a modest recovery following a sharp 14.9% sell-off on July 8. * The current move...
🔴 CNTX makes sharp 11.0% drop
CNTX is trading at $0.62, down 11.0% versus the comparison close of $0.70 during regular trading. This is a price-movement alert; no separate company-specific...
CNTX Pulls Back After Index-Fueled Rally — Can a Sub-Dollar Biotech Sustain Momentum Without Clinical Catalysts?
Shares of Context Therapeutics slid 8.6% to $0.64 on July 8, erasing gains from a sharp rally that lifted the stock roughly 16% over the prior week. The...
🔴 CNTX is trading 8.6% down today after recent analyst-driven rally and Russell index inclusion
CNTX is trading at $0.64 (8.6% down) today as the stock pulls back from a sharp rally fueled by analyst optimism and index inclusion news. • The recent upward...
🟢 CNTX is trading 5% up today on bullish analyst ratings and Russell Index inclusion
• CNTX is trading 5% up today at $0.67 on bullish analyst sentiment and aggressive price targets, alongside its recent inclusion in the Russell 2000 and...
🟢 CNTX makes sharp 10.3% jump
CNTX is trading at $0.67, up 10.3% versus the comparison close of $0.61 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 CNTX is trading 5.2% up today with no clear company-specific catalyst
CNTX is trading at 5.2% up now at $0.64 after a sharp 9.8% gain in the previous session. There are no fresh company-specific headlines, earnings, FDA updates,...
🟢 CNTX makes sharp 10.1% jump
CNTX is trading at $0.61, up 10.1% versus the comparison close of $0.55 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 CNTX is trading 6.3% up today as a technical bounce after recent downside
CNTX is trading 6.3% up today at $0.59, continuing a modest rebound after heavy longer-term downside pressure. • The gain appears to be a technical bounce...
🟢 CNTX is trading 5.1% up today as a modest bounce within a broader downtrend
CNTX is trading 5.1% up today at $0.61 as the stock stages a modest bounce following recent sharp volatility and heavy longer-term downside pressure. • There...
Context Therapeutics Stockholders Approve Increase in Authorized Common Stock to 300 Million
Context Therapeutics Inc. announced that its stockholders have approved an amendment to the company's Certificate of Incorporation to increase the number of...
🟢 CNTX is trading 5.3% up today on technical rebound and bargain hunting
CNTX is trading 5.3% up at $0.59 on a technical rebound and bargain-hunting move following a sharp two-day slide earlier this week. • The current gains appear...
🟢 CNTX is trading 5.3% up today on a technical bounce after recent volatility
CNTX is trading 5.3% up at $0.61 as a technical bounce and bargain-hunting follow yesterday’s double-digit drop. • No fresh company-specific news or filings...
🔴 CNTX makes sharp 10.7% drop
CNTX is trading at $0.58, down 10.7% versus the comparison close of $0.65 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 CNTX is trading 5.1% down today as the rebound from positive CTIM-76 data loses steam
CNTX is trading at $0.62 (5.1% down) as its multi-day rebound, fueled by positive CTIM-76 Phase 1 data and supportive analyst commentary, begins to fade. •...
🟢 CNTX is trading 9.5% up today, extending its rebound on positive CTIM-76 data and analyst support
CNTX is trading 9.5% up at $0.69 as it extends its rebound following last week’s CTIM-76 Phase 1 data and bullish analyst commentary. • Shares are recovering...
🟢 Context Therapeutics Inc gains after positive CTIM-76 Phase 1 trial results and analyst endorsements
• Context Therapeutics Inc is trading at $0.67 (+6.03%) today, rebounding after the company reported positive interim Phase 1 clinical data for its CTIM-76...
🟢 Context Therapeutics Inc is trading 5.2% up today on bargain-hunting after a sharp selloff
Context Therapeutics Inc is trading 5.2% up at $0.63 as shares see a modest rebound following several days of heavy losses linked to clinical trial results. •...
Context Therapeutics Called Its Cancer Data "Positive" — So Why Have Investors Wiped Out 59% of Its Stock in Three Days?
Shares of Context Therapeutics cratered this week after the company released interim Phase 1 results for its lead ovarian cancer drug, raising a brutal...